State alcohol policies environment and remission from alcohol dependence
Methods: An Alcohol Policy Scale (APS) score was created from data on 29 state-level alcohol control policies from the Alcohol Policy Information System and other data sources and weighted by their relative efficacy and degree of implementation for each U.S. state and year from 1999-2001. Data on remission from alcohol dependence were obtained from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) wave 1 (2001-2002). We examined the link between APS scores and remission from alcohol dependence using multilevel logistic regression analysis accounting for clustering among individuals within states.
Results: Among individuals meeting criteria for alcohol dependence, those who resided in states with higher APS scores had higher odds of full remission from alcohol dependence (OR=1.15, 95% CI 1.08, 1.23) compared with those in states with lower APS score. Sensitivity analyses using different lag periods between policy exposure and remission outcomes and different methods of computing APS scores did not substantially change the results.
Summary: More restrictive state-level alcohol policies may help prevent or facilitate remission from clinical alcohol use disorders.
Learning Areas:Conduct evaluation related to programs, research, and other areas of practice
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Public health or related research
Social and behavioral sciences
Describe the relationship between the alcohol policy environment and remission from alcohol dependence.
Keyword(s): Alcohol, Public Health Policy
Qualified on the content I am responsible for because: I have a ScD and 10 years of experience in alcohol research. I have been involved in several NIH funded projects on the topics of alcohol policies, prevention and treatment. I currently serve as a Research Assistant Professor at Boston University.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.